Heart failure learning module 4: invasive treatment of heart failure

Released 24 May 2024     Expires: 24 May 2026      Programme: Heart failure 1.5 CPD/CME credits

Sponsorship Statement: Novartis Pharmaceuticals UK Ltd has provided OmniaMed Communications Ltd with an arm’s length sponsorship towards the update of the BJC e-learning programme for heart failure.

Designed to give healthcare professionals an understanding of other methods of managing heart failure, it is one of several modules in our heart failure programme.

Module first published: 23 September 2014
Revised module released: 01 November 2017
2nd revision released: 07 May 2020
3rd revision released: 24 May 2024
Module revised in 2017, 2020 and 2024 by Dr Joe Cuthbert, (Honorary Consultant Cardiologist, Hull University Teaching Hospitals NHS Trust; Senior Lecturer in Cardiology, Hull York Medical School) in association with Professor Andrew Clark (Chair in Clinical Cardiology, Hull York Medical School)

Learning objectives

After completing this module, participants should be better able to understand:

  • Cardiac resynchronisation therapy – how it works and which patients are suitable for this treatment
  • Other device therapies including implantable cardiac defibrillators
  • The concept of sleep-disordered breathing (SDB) in heart failure and its treatment
  • The role of ultrafiltration in patients with decompensated heart failure, patient selection, and the potential benefits and complications of the procedure
  • The basics of gene therapy, its potential targets, clinical experience, and vectors and delivery systems

Faculty

Dr Joe Cuthbert, Honorary Consultant Cardiologist, Hull University Teaching Hospitals NHS Trust; Senior Lecturer in Cardiology, Hull York Medical School.
In association with Professor Andrew Clark, Chair in Clinical Cardiology, Hull York Medical School

Original faculty

Professor Andrew Clark, Chair in Clinical Cardiology, Hull York Medical School
Professor Martin Cowie, Consultant Cardiologist, Royal Brompton Hospital, London
Dr Kaushik Guha, Clinical Cardiology Research Fellow, Royal Brompton Hospital, London
Dr Carl Hayward, Clinical Research Fellow, Royal Brompton Hospital, London
Dr Muhammad Muzaffar Mahmood, James Cook University Hospital
Dr Thanh Trung Phan, James Cook University Hospital
Dr Henry Savage, Specialist Registrar in Cardiology, Royal Brompton Hospital, London
Dr Rakesh Sharma, Consultant Cardiologist, Royal Brompton Hospital, London
Dr Andrew Turley, Consultant Cardiologist, South Tees Hospitals NHS Trust
Dr Ali Vazir, Consultant Cardiologist, Royal Brompton Hospital, London

Accreditation

1.5 CPD/CME credits, 1.5 hours
BJC Learning has assigned one and a half hours of CPD/CME credit to this module

Endorsed by:

You need to login to take this module

You need to be a registered member to view this page. It's quick, free and offers you a host of other benefits, including the facility to print and download articles and supplements, access our archived issues and receive email updates when new issues and other content are online.

3 thoughts on “Heart failure learning module 4: invasive treatment of heart failure”

All rights reserved. No part of this programme may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publishers, Medinews (Cardiology) Limited.

It shall not, by way of trade or otherwise, be lent, re-sold, hired or otherwise circulated without the publisher’s prior consent.

Medical knowledge is constantly changing. As new information becomes available, changes in treatment, procedures, equipment and the use of drugs becomes necessary. The editors/authors/contributors and the publishers have taken care to ensure that the information given in this text is accurate and up to date. Readers are strongly advised to confirm that the information, especially with regard to drug usage, complies with the latest legislation and standards of practice.

Healthcare professionals should consult up-to-date Prescribing Information and the full Summary of Product Characteristics available from the manufacturers before prescribing any product. Medinews (Cardiology) Limited cannot accept responsibility for any errors in prescribing which may occur.